Hydrocodone Bitartrate And Acetaminophen Tablet
Product Images NDC 53746-110

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Hydrocodone Bitartrate And Acetaminophen (NDC 53746-110). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Of New York Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Hydrocodone Bitartrate And Acetaminophen Tablets 1

Hydrocodone Bitartrate And Acetaminophen Tablets 1
Chemical structure of Hydrocodone Bitartrate and Acetaminophen showing molecular formulas, structural bonds, and hydration state. The image includes molecular weights and chemical groups typical for these compounds.*
FDA Label Image

Hydrocodone Bitartrate And Acetaminophen Tablets 2

Hydrocodone Bitartrate And Acetaminophen Tablets 2
Chemical structure of Hydrocodone Bitartrate and Acetaminophen showing its molecular formula and arrangement of atoms, with a molecular weight of 151.16.*
FDA Label Image

Hydrocodone Bitartrate And Acetaminophen Tablets 3

Hydrocodone Bitartrate And Acetaminophen Tablets 3
Label for Hydrocodone Bitartrate and Acetaminophen Tablets, USP, 10 mg / 325 mg, oral tablets. The label specifies a package of 100 tablets and is manufactured by Amneal Pharmaceuticals of NY LLC. It includes the NDC 53746-110-01, a DEA Schedule II symbol, dispensing instructions, storage conditions, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.